Amphastar Pharmaceuticals(AMPH) - 2025 Q2 - Quarterly Results
Amphastar Pharmaceuticals(US:AMPH)2025-08-07 20:31EXHIBIT 99.1 Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2025 RANCHO CUCAMONGA, CA – August 7, 2025 – Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) ("Amphastar" or the "Company"), a biopharmaceutical company focused on developing, manufacturing, and marketing complex generic and proprietary injectable, inhalation, and intranasal products, today reported results for the three months ended June 30, 2025. "We are pleased to report strong second-quarter performance, ...